Consolidation therapy of arsenic trioxide alternated with chemotherapy achieves remarkable efficacy in newly diagnosed acute promyelocytic leukemia

BACKGROUND: Currently, all-trans retinoic acid (ATRA) combined with daunorubicin and ATRA combined with arsenic trioxide (ATO) therapies are considered the standard induction therapy regimens for adult patients newly diagnosed with acute promyelocytic leukemia (APL). However, there is no consensus c...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Cheng-cheng, Wang, Hua, Wang, Wei-da, Zhu, Meng-yuan, Geng, Qi-rong, Lu, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654542/
https://www.ncbi.nlm.nih.gov/pubmed/26622182
http://dx.doi.org/10.2147/OTT.S92486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654542/
https://www.ncbi.nlm.nih.gov/pubmed/26622182
http://dx.doi.org/10.2147/OTT.S92486

Ejemplares similares